Healthcare / Medical Care FacilitiesThailand
$5.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $61.5M · quality 48.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.0B
P/E
15.6x
↓EV/EBITDA
8.3x
↓ROE
11.1%
↑Gross Margin
41.8%
↓Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.7%
FCF CAGR
—
FCF margin
-6.0%
FCF / Net income
-0.28x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.24B · net income $262.3M · FCF $-74.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.24B | $1.24B | $1.31B | $1.21B | $1.05B |
| Net Income | $262.3M | $262.3M | $280.1M | $297.3M | $551.3M |
| EBITDA | $424.3M | $424.3M | $443.9M | $460.1M | $764.0M |
| EPS | 0.32 | 0.32 | 0.36 | 0.40 | 0.78 |
| Gross Margin | 41.8% | 41.8% | 45.0% | 44.6% | 41.9% |
| Operating Margin | 24.0% | 24.0% | 23.5% | 26.1% | 23.1% |
| Net Margin | 21.2% | 21.2% | 21.4% | 24.6% | 52.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.03 | 0.01 | 0.01 |
| Current Ratio | 4.42 | 4.42 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-74.2M | $-74.2M | $61.5M | $280.0M | $234.8M |
| Returns | |||||
| ROE | 11.1% | 11.1% | 10.5% | 14.1% | 28.9% |
| Valuation | |||||
| P/E | 15.63 | 15.63 | 16.44 | 19.31 | 11.12 |
| EV/EBITDA | 8.32 | 8.32 | 8.39 | 10.84 | 7.04 |
| P/B | 1.72 | 1.72 | 1.72 | 2.73 | 3.21 |
| Growth & Yield | |||||
| Revenue Growth | -5.1% | -5.1% | 8.1% | 15.3% | — |
| EPS Growth | -11.9% | -11.9% | -7.7% | -49.1% | — |
| Dividend Yield | 6.0% | 6.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
11.3%
EPS terminal req.
$0.44
Spread vs growth
-23.3%
5Y implied EPS CAGR
10.8%
EPS terminal req.
$0.54
Spread vs growth
-22.8%
10Y implied EPS CAGR
10.4%
EPS terminal req.
$0.86
Spread vs growth
-22.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.6%
Start / end P/E
17.4x → 15.5x
EPS bridge
0.36 → 0.32
Residual
+1.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.